ORBIMED ADVISORS LLC Insider Trading
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA). Discover the current value of ORBIMED ADVISORS LLC shares.
Address:
ORBIMED ADVISORS LLC is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
XLRN | ACCELERON PHARMA INC | 576,889 | 13,695,344.86 | |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director | 1,120,609 | 127,267,564.13 |
RLYP | Relypsa Inc | 10% Owner | 3,700,000 | 0.00 |
PIRS | PIERIS PHARMACEUTICALS, INC. | 10% Owner, Director | 4,511,130 | 9,924,486.00 |
GKOS | GLAUKOS Corp | Director | 562,839 | 24,950,652.87 |
SRRA | Sierra Oncology, Inc. | Director | 1,477,320 | 2,304,619.20 |
SIEN | Sientra, Inc. | 10% Owner | 17,100 | 143,811.00 |
DMTX | Dimension Therapeutics, Inc. | Director | 5,397,698 | 8,906,201.70 |
OTIC | OTONOMY, INC. | Director | 1,850,094 | 26,826,363.00 |
CRVS | Corvus Pharmaceuticals, Inc. | Director | 8,053,298 | 111,377,111.34 |
NTLA | Intellia Therapeutics, Inc. | Director | 2,662,180 | 35,406,994.00 |
ADAP | Adaptimmune Therapeutics PLC | Director | 4,902,910 | 22,210,182.30 |
RPBIF | RESPONSE BIOMEDICAL CORP | Director | 0 | 0.00 |
SELB | SELECTA BIOSCIENCES INC | Director | 12,193 | 168,629.19 |
BOLD | Audentes Therapeutics, Inc. | 10% Owner, Director | 3,638,000 | 57,589,540.00 |
LOXO | Loxo Oncology, Inc. | Director | 941,000 | 37,357,700.00 |
VRAY | ViewRay, Inc. | 10% Owner, Director | 7,464,378 | 44,413,049.10 |
ROKA | Sorrento Tech, Inc. | 10% Owner, Director | 0 | 0.00 |
AGLE | Aeglea BioTherapeutics, Inc. | 10% Owner | 1,390,724 | 5,827,133.56 |
ARPO | Aerpio Pharmaceuticals, Inc. | 10% Owner, Director | 21,400 | 0.00 |
STDY | SteadyMed Ltd. | 10% Owner | 0 | 0.00 |
CTIC | CTI BIOPHARMA CORP | 10% Owner | 7,520,600 | 35,121,202.00 |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Director | 3,070,955 | 7,186,034.70 |
KALA | Kala Pharmaceuticals, Inc. | 10% Owner | 3,422,840 | |
RYTM | RHYTHM PHARMACEUTICALS, INC. | 10% Owner | 2,751,679 | |
ASNS | X4 Pharmaceuticals, Inc | 10% Owner | 19,533 | |
SCPH | scPharmaceuticals Inc. | 10% Owner | 4,565,948 | |
SYBX | SYNLOGIC, INC. | Director | 3,696,662 | 8,132,656.40 |
ARMO | ARMO BioSciences, Inc. | Director | 3,709,356 | |
TORC | Adicet Bio, Inc. | Director | 5,243,259 | |
XTNT | Xtant Medical Holdings, Inc. | Director | 53,468,376 | 24,060,769.20 |
INSP | Inspire Medical Systems, Inc. | Director, 10% Owner | 43,543 | |
IMRA | IMARA Inc. | Director | 937,500 | |
TCDA | Tricida, Inc. | Director | 9,614,280 | |
CNST | CONSTELLATION PHARMACEUTICALS INC | 10% Owner | 317,921 | |
PRNB | Principia Biopharma Inc. | 10% Owner | 1,605,713 | |
GH | Guardant Health, Inc. | 10% Owner | 1,525,492 | |
SIBN | SI-BONE, Inc. | Director | 605,964 | |
LOGC | LogicBio Therapeutics, Inc. | Director | 3,524,997 | |
THOR | Synthorx, Inc. | Director | 1,363,636 | |
ALEC | Alector, Inc. | 10% Owner, Director | 6,002,771 | |
AVDR | AVEDRO INC | 10% Owner | 3,523,204 | |
TPTX | Turning Point Therapeutics, Inc. | Director | 1,120,730 | |
NXTC | NextCure, Inc. | Director | 445,866 | |
PRVL | Prevail Therapeutics Inc. | Director | 0 | |
SWTX | SpringWorks Therapeutics, Inc. | 10% Owner | 6,078,103 | |
ETNB | 89bio, Inc. | Director | 1,864,721 | |
TELA | TELA Bio, Inc. | 10% Owner | 1,568,627 | |
ARQT | Arcutis Biotherapeutics, Inc. | Director | 4,267,564 | |
KROS | Keros Therapeutics, Inc. | Director | 744,612 | |
ORIC | Oric Pharmaceuticals, Inc. | Director | 2,240,440 | |
RPTX | Repare Therapeutics Inc. | Director | 2,601,325 | |
FUSN | Fusion Pharmaceuticals Inc. | Director | 2,224,770 | |
AFIB | Acutus Medical, Inc. | Director | 373,500 | |
PMVP | PMV Pharmaceuticals, Inc. | Director | 475,000 | |
GRAY | GRAYBUG VISION, INC. | 10% Owner | 562,500 | |
PRLD | Prelude Therapeutics Inc | Director | 526,300 | |
KNTE | Kinnate Biopharma Inc. | 543,494 | ||
SBTX | Silverback Therapeutics, Inc. | Director | 507,423 | |
TERN | Terns Pharmaceuticals, Inc. | Director | 1,326,481 | |
DBTX | Decibel Therapeutics, Inc. | Director | 2,732,106 | |
EWTX | Edgewise Therapeutics, Inc. | Director | 13,046,956 | |
IKNA | Ikena Oncology, Inc. | Director | 1,816,425 | |
NPCE | NeuroPace Inc | 10% Owner | 4,012,281 |
Insider Trading Transactions of ORBIMED ADVISORS LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | 0.00 | 3,777,281 | 0 | 4,012,281 |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 171,895 | 0 | 0 |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 3,605,386 | 0 | 0 |
Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | 17.00 | 235,000 | 3,995,000 | 235,000 |
Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | 17.00 | 235,000 | 3,995,000 | 235,000 |
Apr 22 2021 | SYBX | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Buy | 3.00 | 1,666,666 | 4,999,998 | 3,696,662 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,816,425 | 0 | 1,816,425 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 68,978 | 0 | 68,978 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 375,000 | 6,000,000 | 2,191,425 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 48,400 | 774,400 | 117,378 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 5,083,470 | 0 | 5,083,470 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 130,924 | 0 | 130,924 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 8,938,148 | 0 | 8,938,148 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,430,103 | 0 | 1,430,103 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,905,201 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 680,766 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 2,257,785 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 806,752 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 920,484 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 328,907 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 130,924 | 0 | 0 |
Apr 01 2021 | IKNA | Ikena Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 68,978 | 0 | 0 |
Mar 31 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 23.31 | 75,555 | 1,761,187 | 2,240,440 |
Mar 31 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 23.93 | 27,869 | 666,905 | 2,212,571 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 12,730,036 | 0 | 13,046,956 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 272,724 | 0 | 272,724 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 46,875 | 750,000 | 319,599 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 312,500 | 5,000,000 | 13,359,456 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 8,187,100 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,572,960 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,301,626 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,668,350 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 272,724 | 0 | 0 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 24.80 | 32,959 | 817,383 | 2,395,334 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 24.80 | 32,959 | 817,383 | 2,395,334 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 24.70 | 51,523 | 1,272,618 | 2,343,811 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 24.70 | 51,523 | 1,272,618 | 2,343,811 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 23.88 | 27,816 | 664,246 | 2,315,995 |
Mar 26 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 23.88 | 27,816 | 664,246 | 2,315,995 |
Mar 23 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 26.47 | 21,275 | 563,149 | 2,439,958 |
Mar 23 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 26.47 | 7,673 | 203,104 | 2,432,285 |
Mar 23 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 24.32 | 3,992 | 97,085 | 2,428,293 |
Mar 18 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 27.72 | 41,353 | 1,146,305 | 2,486,082 |
Mar 18 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 28.43 | 18,790 | 534,200 | 2,467,292 |
Mar 18 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 28.03 | 6,059 | 169,834 | 2,461,233 |
Mar 15 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 33.04 | 58,551 | 1,934,525 | 2,707,166 |
Mar 15 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 30.29 | 90,521 | 2,741,881 | 2,616,645 |
Mar 15 2021 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | 29.14 | 89,210 | 2,599,579 | 2,527,435 |
Feb 19 2021 | CRVS | Corvus Pharmaceuticals, I ... | ORBIMED ADVISORS LLC | Director | Buy | 3.50 | 1,285,714 | 4,499,999 | 8,053,298 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,732,106 | 0 | 2,732,106 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 327,852 | 0 | 327,852 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 218,568 | 0 | 218,568 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 1,111,100 | 19,999,800 | 3,843,206 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 555,566 | 10,000,188 | 883,418 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 14,480,162 | 0 | 0 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,737,619 | 0 | 0 |
Feb 19 2021 | DBTX | Decibel Therapeutics, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,158,412 | 0 | 0 |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 13.00 | 420,299 | 5,463,887 | 5,243,259 |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 13.00 | 104,050 | 1,352,650 | 396,657 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,326,481 | 0 | 1,326,481 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,989,723 | 0 | 1,989,723 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 190,000 | 3,230,000 | 1,516,481 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 285,000 | 4,845,000 | 2,274,723 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 714,285 | 0 | 0 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,071,428 | 0 | 0 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 612,196 | 0 | 0 |
Feb 09 2021 | TERN | Terns Pharmaceuticals, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 918,295 | 0 | 0 |
Jan 26 2021 | PRVL | Prevail Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Sell | 0.00 | 13,822,463 | 0 | 0 |
Jan 12 2021 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 41,700 | 0 | 5,596,886 |
Jan 11 2021 | CTIC | CTI BIOPHARMA CORP | ORBIMED ADVISORS LLC | 10% Owner | Sell | 3.50 | 2,000,000 | 7,000,000 | 7,520,600 |
Jan 11 2021 | CTIC | CTI BIOPHARMA CORP | ORBIMED ADVISORS LLC | 10% Owner | Sell | 3.50 | 2,000,000 | 7,000,000 | 7,520,600 |
Dec 30 2020 | ALPN | ALPINE IMMUNE SCIENCES, I ... | ORBIMED ADVISORS LLC | Director | Sell | 14.25 | 600,000 | 8,550,000 | 3,070,955 |
Dec 10 2020 | ARPO | Aerpio Pharmaceuticals, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | 0.96 | 21,400 | 20,544 | 21,400 |
Dec 10 2020 | ARPO | Aerpio Pharmaceuticals, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | 1.96 | 21,400 | 41,944 | 0 |
Dec 10 2020 | ARPO | Aerpio Pharmaceuticals, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | 0.96 | 21,400 | 20,544 | 0 |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 243,494 | 0 | 543,494 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 2,651,042 | 0 | 3,194,536 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 118,794 | 0 | 3,313,330 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 50,501 | 0 | 50,501 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 9,461 | 0 | 59,962 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 0.00 | 24,637 | 0 | 84,599 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 243,494 | 0 | 0 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 2,651,042 | 0 | 0 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 118,398 | 0 | 0 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 50,501 | 0 | 0 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 9,461 | 0 | 0 | |
Dec 09 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Option Exercise | 0.00 | 24,555 | 0 | 0 | |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 21.00 | 238,100 | 5,000,100 | 507,423 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 21.00 | 238,100 | 5,000,100 | 507,423 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 3,462,737 | 0 | 3,970,160 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 3,462,737 | 0 | 3,970,160 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,493,741 | 0 | 6,463,901 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,493,741 | 0 | 6,463,901 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,055,287 | 0 | 7,519,188 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,055,287 | 0 | 7,519,188 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 21.00 | 952,377 | 19,999,917 | 952,377 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 21.00 | 952,377 | 19,999,917 | 952,377 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 12,857,142 | 0 | 0 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 12,857,142 | 0 | 0 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 9,259,259 | 0 | 0 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 9,259,259 | 0 | 0 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 3,918,279 | 0 | 0 |
Dec 08 2020 | SBTX | Silverback Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 3,918,279 | 0 | 0 |
Dec 04 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 20.00 | 300,000 | 6,000,000 | 300,000 | |
Dec 04 2020 | KNTE | Kinnate Biopharma Inc. | ORBIMED ADVISORS LLC | Buy | 20.00 | 450,000 | 9,000,000 | 450,000 | |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 765,992 | 7,660 | 53,468,376 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 765,992 | 7,660 | 54,234,368 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 1,531,984 | 15,320 | 55,766,352 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 434,008 | 4,340 | 15,734,696 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 434,008 | 4,340 | 16,168,704 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.01 | 868,016 | 8,680 | 17,036,720 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 765,992 | 7,660 | 0 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 434,008 | 4,340 | 0 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 765,992 | 7,660 | 0 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 434,008 | 4,340 | 0 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 1,531,984 | 15,320 | 0 |
Nov 19 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 868,016 | 8,680 | 0 |
Oct 06 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 25.00 | 200,000 | 5,000,000 | 4,267,564 |
Oct 06 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 25.00 | 296,000 | 7,400,000 | 902,286 |
Oct 05 2020 | LOGC | LogicBio Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 6.00 | 545,974 | 3,275,844 | 3,524,997 |
Oct 05 2020 | LOGC | LogicBio Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 6.00 | 639,212 | 3,835,272 | 4,126,972 |
Oct 05 2020 | LOGC | LogicBio Therapeutics, In ... | ORBIMED ADVISORS LLC | Director | Buy | 6.00 | 296,296 | 1,777,776 | 296,296 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 475,000 | 8,550,000 | 475,000 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 4,025,076 | 0 | 4,500,076 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,076,891 | 0 | 5,576,967 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 518,191 | 0 | 6,095,158 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 380,133 | 0 | 6,475,291 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 114,039 | 0 | 114,039 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 475,000 | 8,550,000 | 475,000 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 4,025,076 | 0 | 0 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,076,891 | 0 | 0 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 518,191 | 0 | 0 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 380,133 | 0 | 0 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 114,039 | 0 | 0 |
Sep 29 2020 | GRAY | GRAYBUG VISION, INC. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 16.00 | 562,500 | 9,000,000 | 562,500 |
Sep 29 2020 | GRAY | GRAYBUG VISION, INC. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 0.00 | 3,600,847 | 0 | 4,163,347 |
Sep 29 2020 | GRAY | GRAYBUG VISION, INC. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 2,754,273 | 0 | 0 |
Sep 29 2020 | GRAY | GRAYBUG VISION, INC. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 846,574 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Buy | 19.00 | 526,300 | 9,999,700 | 526,300 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Buy | 19.00 | 710,500 | 13,499,500 | 917,412 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 8,332,779 | 0 | 9,250,191 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 3,294,743 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 2,196,494 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 4,418,186 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 2,945,458 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 619,850 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 413,234 | 0 | 0 |
Sep 29 2020 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 5,555,186 | 0 | 5,555,186 |
Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | 28.00 | 137,500 | 3,850,000 | 1,864,721 |
Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | 28.00 | 137,500 | 3,850,000 | 1,864,721 |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 4,822,960 | 0 | 4,822,960 |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 902,885 | 0 | 902,855 |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 292,607 | 0 | 292,607 |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 16.11 | 30,000 | 483,300 | 30,000 |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 16.11 | 30,000 | 483,300 | 30,000 |
Aug 19 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 107.49 | 94,900 | 10,200,801 | 43,543 |
Aug 19 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 108.54 | 43,543 | 4,726,157 | 0 |
Aug 14 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 107.45 | 42,679 | 4,585,859 | 187,751 |
Aug 14 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 109.93 | 29,251 | 3,215,562 | 158,500 |
Aug 14 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 109.03 | 20,257 | 2,208,621 | 138,443 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 373,500 | 6,723,000 | 373,500 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 18.00 | 41,500 | 747,000 | 41,500 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 3,784,240 | 0 | 4,157,740 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,278,718 | 0 | 1,320,218 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 872,302 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 673,123 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 647,582 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 899,985 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 389,116 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,202,117 | 0 | 0 |
Aug 12 2020 | AFIB | Acutus Medical, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 378,733 | 0 | 0 |
Aug 11 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 106.18 | 28,993 | 3,078,477 | 318,007 |
Aug 11 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 105.23 | 47,700 | 5,019,471 | 270,307 |
Aug 11 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 105.78 | 39,877 | 4,218,189 | 230,430 |
Jul 02 2020 | FUSN | Fusion Pharmaceuticals In ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,224,770 | 0 | 2,224,770 |
Jul 02 2020 | FUSN | Fusion Pharmaceuticals In ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 705,900 | 12,000,300 | 2,930,670 |
Jul 02 2020 | FUSN | Fusion Pharmaceuticals In ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 192,100 | 3,265,700 | 192,100 |
Jul 02 2020 | FUSN | Fusion Pharmaceuticals In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 11,878,051 | 0 | 0 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,601,325 | 0 | 2,601,325 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Buy | 20.00 | 675,000 | 13,500,000 | 3,276,325 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Buy | 20.00 | 99,200 | 1,984,000 | 99,200 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 2,601,325 | 0 | 0 |
May 26 2020 | SCPH | scPharmaceuticals Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 |
May 26 2020 | SCPH | scPharmaceuticals Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 8.65 | 231,200 | 1,999,880 | 231,200 |
May 26 2020 | SCPH | scPharmaceuticals Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 |
May 26 2020 | SCPH | scPharmaceuticals Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | 8.65 | 231,200 | 1,999,880 | 231,200 |
May 20 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 1,531,984 | 15,320 | 1,531,984 |
May 20 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.01 | 868,016 | 8,680 | 868,016 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 281,250 | 4,500,000 | 281,250 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,875,000 | 0 | 2,156,250 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 373,356 | 0 | 2,529,606 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 236,111 | 0 | 2,765,717 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 1,875,000 | 0 | 0 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 373,356 | 0 | 0 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 236,111 | 0 | 0 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.52 | 17,595 | 413,834 | 6,002,771 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.52 | 5,636 | 132,559 | 1,921,804 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.53 | 47,097 | 1,108,192 | 5,955,674 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.53 | 15,086 | 354,974 | 1,906,718 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.52 | 17,595 | 413,834 | 6,002,771 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.52 | 5,636 | 132,559 | 1,921,804 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.53 | 47,097 | 1,108,192 | 5,955,674 |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.53 | 15,086 | 354,974 | 1,906,718 |
Apr 13 2020 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 744,612 | 0 | 744,612 |
Apr 13 2020 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 148,922 | 0 | 148,922 |
Apr 13 2020 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 375,200 | 6,003,200 | 1,119,812 |
Apr 13 2020 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 744,612 | 0 | 0 |
Apr 13 2020 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 148,922 | 0 | 0 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.10 | 6,946 | 160,453 | 6,301,147 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.10 | 2,224 | 51,374 | 2,017,374 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.65 | 62,573 | 1,479,851 | 6,238,574 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.65 | 20,041 | 473,970 | 1,997,333 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.79 | 218,208 | 5,191,168 | 6,020,366 |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 23.79 | 69,893 | 1,662,754 | 1,927,440 |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.50 | 189,355 | 4,639,198 | 6,308,093 |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.50 | 60,645 | 1,485,803 | 2,019,598 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26.05 | 11,057 | 288,035 | 6,591,410 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26.05 | 3,541 | 92,243 | 2,110,336 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.45 | 51,235 | 1,252,696 | 6,540,175 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.45 | 16,409 | 401,200 | 2,093,927 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.66 | 42,727 | 1,053,648 | 6,497,448 |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24.66 | 13,684 | 337,447 | 2,080,243 |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Buy | 16.00 | 937,500 | 15,000,000 | 937,500 |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,594,902 | 0 | 2,532,402 |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 10,046,294 | 0 | 0 |
Mar 10 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 83.52 | 500,000 | 41,760,000 | 347,000 |
Mar 05 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 83.21 | 75,000 | 6,240,750 | 1,272,000 |
Mar 05 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 84.55 | 25,000 | 2,113,750 | 1,247,000 |
Mar 05 2020 | INSP | Inspire Medical Systems, ... | ORBIMED ADVISORS LLC | Director | Sell | 84.42 | 400,000 | 33,768,000 | 847,000 |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26.00 | 1,390,309 | 36,148,034 | 6,602,467 |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26.00 | 445,086 | 11,572,236 | 2,113,877 |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26.00 | 38,808 | 1,009,008 | 0 |
Feb 07 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 70,423 | 0 | 91,256 |
Feb 07 2020 | XTNT | Xtant Medical Holdings, I ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 70,423 | 0 | 91,256 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 382,388 | 6,500,596 | 382,388 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 17.00 | 176,500 | 3,000,500 | 176,500 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 2,825,603 | 0 | 3,207,991 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 859,573 | 0 | 4,067,564 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 429,786 | 0 | 606,286 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 2,825,603 | 0 | 0 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 859,573 | 0 | 0 |
Feb 04 2020 | ARQT | Arcutis Biotherapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 429,786 | 0 | 0 |
Jan 31 2020 | SRRA | Sierra Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Buy | 0.00 | 1,477,320 | 0 | 1,477,320 |
Jan 31 2020 | SRRA | Sierra Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | 0.00 | 19,500 | 0 | 0 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 286,787 | 5,592,347 | 7,992,776 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 91,818 | 1,790,451 | 2,558,963 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 1,392 | 27,144 | 38,808 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 286,787 | 5,592,347 | 7,992,776 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 91,818 | 1,790,451 | 2,558,963 |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | 19.50 | 1,392 | 27,144 | 38,808 |